Health Technology Assessment (HTA) in Japan’s reimbursement system evaluates medical devices’ clinical effectiveness, safety, cost-effectiveness, & impact on healthcare. Managed by MHLW & Chuikyo, HTA informs pricing & coverage decisions within the National Health Insurance framework. It ensures resources are allocated efficiently while maintaining high-quality, patient-centered care standards in Japan’s healthcare system.
